Evidence mapPaperPMID 40406415Full record

ReviewFrontiers in cell and developmental biology2025

Molecular dynamics of inflammation resolution: therapeutic implications.

Amro M Soliman, Mohamed Soliman, Syed Sajid Hussain Shah, Habeeb Ali Baig, Nawal Salama Gouda, Bandar Theyab Alenezi, Awwad Alenezy, Ahmed M S Hegazy, Muhammad Jan, Elhassan Hussein Eltom

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Quantifying Information Exchange Between Cells in Inflammaging.Bioengineering (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amro M SolimanDepartment of Biological Sciences, Faculty of Science, Concordia University of Edmonton, Edmonton, AB, Canada.
Mohamed SolimanDepartment of Microbiology, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Syed Sajid Hussain ShahDepartment of Pathology, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Habeeb Ali BaigDepartment of Microbiology, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Nawal Salama GoudaDepartment of Microbiology, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Bandar Theyab AleneziDepartment of Pharmacology, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Awwad AlenezyDepartment of Family and Community Medicine, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Ahmed M S HegazyDepartment of Anatomy, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Muhammad JanDepartment of Pharmacology, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.
Elhassan Hussein EltomDepartment of Pharmacology, Faculty of Medicine, Northern Border University, Arar, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a critical part of innate immune response that is essential for exclusion of harmful stimuli and restoration of tissue homeostasis. Nonetheless, failure to resolve inflammation results in chronic inflammatory conditions, including autoimmune diseases. Conventionally, resolution of inflammation was deemed a passive process; however, evidence indicates that it entails active, highly regulated molecular and cellular events involving efferocytosis-driven macrophage reprogramming, post-transcriptional regulatory mechanisms and the production of specialized pro-resolving mediators (SPMs). These processes collectively restore tissue homeostasis and prevent chronic inflammation. Emerging therapeutic approaches targeting these pathways demonstrate promising results in preclinical studies and clinical trials, enhancing resolution and improving overall disease outcome. This resulted in a paradigm shift from conventional anti-inflammatory strategies to resolution-focused treatment. Yet, challenges remain due to the complexity of resolution mechanisms and tissue-specific differences. This review summarizes current advances in inflammation resolution, emphasizing emerging concepts of resolution pharmacology. By employing endogenous mechanisms facilitating resolution, novel therapeutic applications can effectively manage several chronic inflammatory disorders.

Indexed as

acute inflammationproinflammatory pathwaysresolutionresolution pharmacologyspecialized pro-resolving molecules

Identifiers

PMID40406415
PMCPMC12095172

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.